Gesellschaftsrecht / M&A

Kapitalmarkt

Anlageprodukte

Finanzierungen

Homburger News

Share-Image Teamplate Deals-and-Cases

Homburger advises Santhera on its licensing of AGAMREE® to Nxera Pharma in APAC countries 

On January 8, 2026, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced that it had signed an exclusive licensing agreement with Nxera Pharma, a biopharmaceutical company listed on the Tokyo Stock Exchange, for the development, manufacturing and commercialization of AGAMREE® for the treatment of Duchenne muscular dystrophy in Japan, South Korea, Australia and New Zealand. Santhera will receive a USD 30 m cash upfront payment and a USD 10 m equity investment through the purchase of c. 530 k shares by Nxera at a 20 % premium to the 30-day VWAP.
Homburger advises Santhera on the Swiss corporate, capital markets and financing aspects of the transaction. The Homburger team is led by Daniel Häusermann and includes Marco Rostetter (both Corporate / M&amp;A, Capital Markets) and Eduard De Zordi (Financing, Investment Products, Capital Markets).

Immobilien

Steuern

Homburger advised Yoda PLC on Ultima Capital SA’s CHF 100 m common bond loan

Homburger acted as counsel to Yoda PLC in respect of a new CHF 100 m common bond loan issued by Ultima Capital SA and subscribed for by National Bank of Greece S.A. Ultima Capital SA is a luxury real estate company that holds and develops a portfolio of high-end real estate assets in Switzerland, France and Greece.
The Homburger team advising on all Swiss aspects of the financing transaction was co-led by Stefan Bindschedler (Financing) and Lorenzo Togni (Capital Markets) and included Micha Fankhauser and Jonas Stähli (both Corporate / M&amp;A), Eduard De Zordi and Samuel Fäh (both Capital Markets, Financing), Claudia Suter, Stefan Oesterhelt, Philippe Gobet and Philippe Weber (all Tax) as well as Stefan Gäumann and Olivier Bühlmann (both Real Estate).

Homburger advised Siegfried Holding AG on the issuance of its CHF 300 m bonds

On October 8, 2025, Siegfried Holding AG successfully priced the offering of its CHF 300 m 1.3% bonds.
Zürcher Kantonalbank and Commerzbank Aktiengesellschaft acted as managers. The bonds will be listed on the SIX Swiss Exchange.
Homburger acted as counsel to Siegfried Holding AG. The Homburger team consisted of Benjamin Leisinger and Eduard De Zordi (both Capital Markets).

Er betreut unter anderem die Emission von Forderungsrechten. Zu seinen weiteren Tätigkeitsfeldern gehören das Vertrags- und das Gesellschaftsrecht. Eduard De Zordi ist im Anwaltsregister des Kantons Zürich eingetragen und ist anerkannter Vertreter bei der SIX Swiss Exchange.

Eduard
De Zordi

Homburger advises Santhera on its licensing of AGAMREE® to Nxera Pharma in APAC countries

Homburger advised Yoda PLC on Ultima Capital SA’s CHF 100 m common bond loan

Homburger advised Siegfried Holding AG on the issuance of its CHF 300 m bonds

First bond listed on SIX Digital Exchange in Switzerland

New Swiss financial market rules: a guide

Discontinuation of LIBOR and Swiss Law-Governed Legacy Bonds – Time to Take a Closer Look

Join the Team

Eduard De Zordi

Karriere

Sprachen

Zulassung

Teams

EduardDe Zordi

Homburger advises Santhera on its licensing of AGAMREE® to Nxera Pharma in APAC countries

Homburger advised Yoda PLC on Ultima Capital SA’s CHF 100 m common bond loan

Homburger advised Siegfried Holding AG on the issuance of its CHF 300 m bonds

First bond listed on SIX Digital Exchange in Switzerland

New Swiss financial market rules: a guide

Discontinuation of LIBOR and Swiss Law-Governed Legacy Bonds – Time to Take a Closer Look

Join the Team

Eduard De Zordi

Karriere

Sprachen

Zulassung

Teams

Eduard
De Zordi